Skip to main content
. 2022 Jul 19;12(7):109. doi: 10.1038/s41408-022-00702-9

Table 3.

Treatment of patients and response to treatment.

n Range, %
Route of administration
  iv 330 64.3
  sc 183 35.7
 Time to treatment (months, median) 1.2 0.1–261.8
Blood count recovery
  White blood cell count (day, median) 30 4–302
  Platelet count (day, median) 22 6–300
  Hemoglobin (day, median) 50 7–182
 Time to evaluation of response (months, median) 3.3 0.3–9.8
Response
  CR 335 65.3
  PR 96 18.7
  HR 40 7.8
  NR 42 8.2
Second course 25
  CR 13 52
  PR 5 20
  HR 2 8
  NR 5 20
Status
  Alive 464 90.5
  Dead 49 9.5
  OS at 25 years, % 66 50.7–85.6

CR complete response, PR partial response, HR hematological response, NR no response.